Showing results (421-430 of 467) with videos related to

Sort By:
Pageof 47
Clinical Epigenetics|April 29, 2017
Aberrant DNA methylation and expression of SPDEF and FOXA2 in airway epithelium of patients with COPDJ Song, I H Heijink, L E M Kistemaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, L S Hofstra, et al.
Allergy|December 9, 2009
TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopyN E Reijmerink, R W B Bottema, M Kerkhof, et al.
The European Respiratory Journal|February 26, 2011
Toll-like receptors and microbial exposure: gene-gene and gene-environment interaction in the development of atopyN E Reijmerink, M Kerkhof, R W B Bottema, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 23, 2013
Perinatal risk factors for wheezing phenotypes in the first 8 years of lifeD Caudri, O E M Savenije, H A Smit, et al.
The New England Journal of Medicine|November 12, 1992
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study GroupH A Kerstjens, P L Brand, M D Hughes, et al.
Clinical and Experimental Immunology|February 18, 2009
Exploring the role of polymorphisms in ficolin genes in respiratory tract infections in childrenJ M Ruskamp, M O Hoekstra, D S Postma, et al.
The European Respiratory Journal|March 2, 2010
HMOX1 and GST variants modify attenuation of FEF25-75% decline due to PM10 reductionI Curjuric, M Imboden, C Schindler, et al.
Scientific Reports|March 8, 2019
Age-related gene and miRNA expression changes in airways of healthy individualsJ Ong, R R Woldhuis, I M Boudewijn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 24, 2024
Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the NetherlandsV D de Jager, B N Cajiao Garcia, C C H J Kuijpers, et al.
Pageof 47